Variant report
Variant | esv2443570 |
---|---|
Chromosome Location | chr5:45371731-45376991 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368065242 | chr5:45376424-45376425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370745942 | chr5:45376425-45376426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375604671 | chr5:45376431-45376432 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368385124 | chr5:45376434-45376435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182270536 | chr5:45376436-45376437 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs201682954 | chr5:45376440-45376441 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs372754621 | chr5:45376441-45376442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs550138135 | chr5:45376449-45376450 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187341389 | chr5:45376451-45376452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374514550 | chr5:45376452-45376453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs13188682 | chr5:45376453-45376454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs144163740 | chr5:45376455-45376456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200787164 | chr5:45376457-45376458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574587436 | chr5:45376468-45376469 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs76739492 | chr5:45376489-45376490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190026618 | chr5:45376518-45376519 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs35485064 | chr5:45376552-45376553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577169947 | chr5:45376558-45376559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182298172 | chr5:45376575-45376576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114866075 | chr5:45376592-45376593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs115551716 | chr5:45376603-45376604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541894268 | chr5:45376655-45376656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185141492 | chr5:45376690-45376691 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs190304605 | chr5:45376692-45376693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372484551 | chr5:45376706-45376707 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs547059783 | chr5:45376717-45376718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565719630 | chr5:45376766-45376767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564479336 | chr5:45376774-45376775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs116071311 | chr5:45376779-45376780 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549934266 | chr5:45376780-45376781 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139577013 | chr5:45376782-45376783 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529234573 | chr5:45376811-45376812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576852363 | chr5:45376840-45376841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549474903 | chr5:45376848-45376849 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs149786527 | chr5:45376872-45376873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566130150 | chr5:45376880-45376881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145760897 | chr5:45376888-45376889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534837161 | chr5:45376900-45376901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200083807 | chr5:45376906-45376907 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554001641 | chr5:45376917-45376918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs557641115 | chr5:45376939-45376940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164920 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:45376400-45377200 | Enhancers | HUVEC | blood vessel |
2 | chr5:45376400-45380200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |